Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Other financing activities (2023 - 2024)

BrightSpring Health Services posted quarterly Other financing activities of $3.6 million for Q4 2024, up 2491.97% year-on-year from $137000.0 in Q1 2024, and up 597.64% on a QoQ basis from $509000.0 in Q3 2024.

BrightSpring Health Services (BTSG) has 2 years of Other financing activities data on file, last reported at $3.6 million in Q4 2024.

  • For the quarter ending Q4 2024, Other financing activities rose 2491.97% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2024 stood at $47.0 million (up 6300.68% YoY), and the FY2024 full-year result was $47.0 million, up 6300.68% from the prior year.
  • Other financing activities for Q4 2024 stood at $3.6 million, up from $509000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $43.0 million in Q1 2024 and bottomed at $22000.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Teladoc Health 1.42 Bn 672.39 Mn 562.57 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 3.55 Mn
Dec 31, 2024 3.55 Mn
Sep 30, 2024 509,000.00
Sep 30, 2024 509,000.00
Jun 30, 2024 22,000.00
Jun 30, 2024 22,000.00
Mar 31, 2024 42.96 Mn
Mar 31, 2024 42.96 Mn
Dec 31, 2023 137,000.00
Dec 31, 2023 137,000.00
Sep 30, 2023 453,000.00
Sep 30, 2023 453,000.00
Mar 31, 2023 145,000.00
Mar 31, 2023 145,000.00